Management of cutaneous metastases using electrochemotherapy

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Management of cutaneous metastases using electrochemotherapy. / Matthiessen, Louise Wichmann; Chalmers, Richard Ling; Sainsbury, David Christopher George; Veeramani, Sivakumar; Kessell, Gareth; Humphreys, Alison Claire; Bond, Jane Elisabeth; Muir, Tobian; Gehl, Julie.

In: Acta Oncologica, Vol. 50, No. 5, 2011, p. 621-9.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Matthiessen, LW, Chalmers, RL, Sainsbury, DCG, Veeramani, S, Kessell, G, Humphreys, AC, Bond, JE, Muir, T & Gehl, J 2011, 'Management of cutaneous metastases using electrochemotherapy', Acta Oncologica, vol. 50, no. 5, pp. 621-9. https://doi.org/10.3109/0284186X.2011.573626

APA

Matthiessen, L. W., Chalmers, R. L., Sainsbury, D. C. G., Veeramani, S., Kessell, G., Humphreys, A. C., Bond, J. E., Muir, T., & Gehl, J. (2011). Management of cutaneous metastases using electrochemotherapy. Acta Oncologica, 50(5), 621-9. https://doi.org/10.3109/0284186X.2011.573626

Vancouver

Matthiessen LW, Chalmers RL, Sainsbury DCG, Veeramani S, Kessell G, Humphreys AC et al. Management of cutaneous metastases using electrochemotherapy. Acta Oncologica. 2011;50(5):621-9. https://doi.org/10.3109/0284186X.2011.573626

Author

Matthiessen, Louise Wichmann ; Chalmers, Richard Ling ; Sainsbury, David Christopher George ; Veeramani, Sivakumar ; Kessell, Gareth ; Humphreys, Alison Claire ; Bond, Jane Elisabeth ; Muir, Tobian ; Gehl, Julie. / Management of cutaneous metastases using electrochemotherapy. In: Acta Oncologica. 2011 ; Vol. 50, No. 5. pp. 621-9.

Bibtex

@article{f24c25c908fc42f0b739eb5b77a09000,
title = "Management of cutaneous metastases using electrochemotherapy",
abstract = "Cutaneous metastases may cause considerable discomfort as a consequence of ulceration, oozing, bleeding and pain. Electrochemotherapy has proven to be highly effective in the treatment of cutaneous metastases. Electrochemotherapy utilises pulses of electricity to increase the permeability of the cell membrane and thereby augment the effect of chemotherapy. For the drug bleomycin, the effect is enhanced several hundred-fold, enabling once-only treatment. The primary endpoint of this study is to evaluate the efficacy of electrochemotherapy as a palliative treatment.",
author = "Matthiessen, {Louise Wichmann} and Chalmers, {Richard Ling} and Sainsbury, {David Christopher George} and Sivakumar Veeramani and Gareth Kessell and Humphreys, {Alison Claire} and Bond, {Jane Elisabeth} and Tobian Muir and Julie Gehl",
year = "2011",
doi = "http://dx.doi.org/10.3109/0284186X.2011.573626",
language = "English",
volume = "50",
pages = "621--9",
journal = "Acta Oncologica",
issn = "1100-1704",
publisher = "Taylor & Francis",
number = "5",

}

RIS

TY - JOUR

T1 - Management of cutaneous metastases using electrochemotherapy

AU - Matthiessen, Louise Wichmann

AU - Chalmers, Richard Ling

AU - Sainsbury, David Christopher George

AU - Veeramani, Sivakumar

AU - Kessell, Gareth

AU - Humphreys, Alison Claire

AU - Bond, Jane Elisabeth

AU - Muir, Tobian

AU - Gehl, Julie

PY - 2011

Y1 - 2011

N2 - Cutaneous metastases may cause considerable discomfort as a consequence of ulceration, oozing, bleeding and pain. Electrochemotherapy has proven to be highly effective in the treatment of cutaneous metastases. Electrochemotherapy utilises pulses of electricity to increase the permeability of the cell membrane and thereby augment the effect of chemotherapy. For the drug bleomycin, the effect is enhanced several hundred-fold, enabling once-only treatment. The primary endpoint of this study is to evaluate the efficacy of electrochemotherapy as a palliative treatment.

AB - Cutaneous metastases may cause considerable discomfort as a consequence of ulceration, oozing, bleeding and pain. Electrochemotherapy has proven to be highly effective in the treatment of cutaneous metastases. Electrochemotherapy utilises pulses of electricity to increase the permeability of the cell membrane and thereby augment the effect of chemotherapy. For the drug bleomycin, the effect is enhanced several hundred-fold, enabling once-only treatment. The primary endpoint of this study is to evaluate the efficacy of electrochemotherapy as a palliative treatment.

U2 - http://dx.doi.org/10.3109/0284186X.2011.573626

DO - http://dx.doi.org/10.3109/0284186X.2011.573626

M3 - Journal article

VL - 50

SP - 621

EP - 629

JO - Acta Oncologica

JF - Acta Oncologica

SN - 1100-1704

IS - 5

ER -

ID: 40153336